Summary

The global embolic protection devices market exhibited strong growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of 8.4% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

Embolic protection devices (EPD) trap blood and luminal debris within the saphenous vein graft (SVG) during stenting to prevent distal embolization. There are three classes of these devices, including distal occlusion devices, distal filters and proximal occlusion devices. These devices provide the most verified strategy to reduce periprocedural myocardial infarction (MI) and major adverse cardiovascular events by capturing and removing debris that may get dislodged during surgical procedures such as SVG interventions, percutaneous coronary intervention, aortic valve stenosis, etc..

The increasing prevalence of cardiovascular diseases (CVDs) represent one of the key factors driving the market growth. EPDs are crucial in reducing complications arising due to blockages in small blood vessels caused by the debris that is released into the bloodstream. They form a part of the most reliable, evidence-based procedure for reducing periprocedural MI and other major cardiovascular events. This, coupled with increasing instances of cardiac arrests and other heart-related issues, is providing a significant boost to the market for EPDs. Furthermore, governments of several nations across the globe are investing in increasing their research and development (R&D) capabilities, which is acting as another major growth-inducing factor. Steadily increasing geriatric population across the world, which is more susceptible to chronic medical illnesses, is also contributing to the market growth. The rising demand for minimally invasive products and several technological advancements, along with the significant growth in the healthcare sector, are some of the other factors that are expected to further create a positive outlook for the market.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global embolic protection devices market report, along with forecasts for growth at the global, regional and country-level from 2021-2026. Our report has categorized the market based on region, product, application, procedure, material, usage, and end-user.

Breakup by Product:

Distal Filter Devices
Distal Occlusion Devices
Proximal Occlusion Devices

Breakup by Application:

Coronary Artery Treatment
Carotid Artery Treatment
Others

Breakup by Procedure:

Percutaneous Coronary Intervention
Carotid Artery Stenosis
Saphenous Vein Graft Intervention
Aortic Valve Stenosis (Transcatheter Aortic Valve Replacement)
Others

Breakup by Material:

Nitinol
Polyurethane

Breakup by Usage:

Disposable Devices
Re-Usable Devices

Breakup by End-User:

Hospitals and Clinics
Ambulatory Surgical Centers
Others

Breakup by Region:

North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa


Competitive Landscape:

The competitive landscape of the industry has also been examined with some of the key players being Abbott Laboratories, Allium Medical Solutions Ltd., Boston Scientific Corporation, Cardinal Health Inc., Contego Medical LLC, Innovative Cardiovascular Solutions LLC, Edwards Lifesciences Corporation, Medtronic Inc., Silk Road Medical Inc., etc. Key Questions Answered in This Report:

How has the global embolic protection devices market performed so far and how will it perform in the coming years?
What are the key regional markets?
What has been the impact of COVID-19 on the global embolic protection devices market?
What is the breakup of the market based on the product?
What is the breakup of the market based on the application?
What is the breakup of the market based on the procedure?
What is the breakup of the market based on the material?
What is the breakup of the market based on the usage?
What is the breakup of the market based on the end-user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global embolic protection devices market and who are the key players?
What is the degree of competition in the industry?

ページTOPに戻る

Table of Contents

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Embolic Protection Devices Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product
6.1 Distal Filter Devices
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Distal Occlusion Devices
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Proximal Occlusion Devices
6.3.1 Market Trends
6.3.2 Market Forecast
7 Market Breakup by Application
7.1 Coronary Artery Treatment
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Carotid Artery Treatment
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Others
7.3.1 Market Trends
7.3.2 Market Forecast
8 Market Breakup by Procedure
8.1 Percutaneous Coronary Intervention
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Carotid Artery Stenosis
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Saphenous Vein Graft Intervention
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Aortic Valve Stenosis (Transcatheter Aortic Valve Replacement)
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Others
8.5.1 Market Trends
8.5.2 Market Forecast
9 Market Breakup by Material
9.1 Nitinol
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Polyurethane
9.2.1 Market Trends
9.2.2 Market Forecast
10 Market Breakup by Usage
10.1 Disposable Devices
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Re-Usable Devices
10.2.1 Market Trends
10.2.2 Market Forecast
11 Market Breakup by End-User
11.1 Hospitals and Clinics
11.1.1 Market Trends
11.1.2 Market Forecast
11.2 Ambulatory Surgical Centers
11.2.1 Market Trends
11.2.2 Market Forecast
11.3 Others
11.3.1 Market Trends
11.3.2 Market Forecast
12 Market Breakup by Region
12.1 North America
12.1.1 United States
12.1.1.1 Market Trends
12.1.1.2 Market Forecast
12.1.2 Canada
12.1.2.1 Market Trends
12.1.2.2 Market Forecast
12.2 Asia Pacific
12.2.1 China
12.2.1.1 Market Trends
12.2.1.2 Market Forecast
12.2.2 Japan
12.2.2.1 Market Trends
12.2.2.2 Market Forecast
12.2.3 India
12.2.3.1 Market Trends
12.2.3.2 Market Forecast
12.2.4 South Korea
12.2.4.1 Market Trends
12.2.4.2 Market Forecast
12.2.5 Australia
12.2.5.1 Market Trends
12.2.5.2 Market Forecast
12.2.6 Indonesia
12.2.6.1 Market Trends
12.2.6.2 Market Forecast
12.2.7 Others
12.2.7.1 Market Trends
12.2.7.2 Market Forecast
12.3 Europe
12.3.1 Germany
12.3.1.1 Market Trends
12.3.1.2 Market Forecast
12.3.2 France
12.3.2.1 Market Trends
12.3.2.2 Market Forecast
12.3.3 United Kingdom
12.3.3.1 Market Trends
12.3.3.2 Market Forecast
12.3.4 Italy
12.3.4.1 Market Trends
12.3.4.2 Market Forecast
12.3.5 Spain
12.3.5.1 Market Trends
12.3.5.2 Market Forecast
12.3.6 Russia
12.3.6.1 Market Trends
12.3.6.2 Market Forecast
12.3.7 Others
12.3.7.1 Market Trends
12.3.7.2 Market Forecast
12.4 Latin America
12.4.1 Brazil
12.4.1.1 Market Trends
12.4.1.2 Market Forecast
12.4.2 Mexico
12.4.2.1 Market Trends
12.4.2.2 Market Forecast
12.4.3 Others
12.4.3.1 Market Trends
12.4.3.2 Market Forecast
12.5 Middle East and Africa
12.5.1 Market Trends
12.5.2 Market Breakup by Country
12.5.3 Market Forecast
13 SWOT Analysis
13.1 Overview
13.2 Strengths
13.3 Weaknesses
13.4 Opportunities
13.5 Threats
14 Value Chain Analysis
15 Porters Five Forces Analysis
15.1 Overview
15.2 Bargaining Power of Buyers
15.3 Bargaining Power of Suppliers
15.4 Degree of Competition
15.5 Threat of New Entrants
15.6 Threat of Substitutes
16 Price Indicators
17 Competitive Landscape
17.1 Market Structure
17.2 Key Players
17.3 Profiles of Key Players
17.3.1 Abbott Laboratories
17.3.1.1 Company Overview
17.3.1.2 Product Portfolio
17.3.1.3 Financials
17.3.1.4 SWOT Analysis
17.3.2 Allium Medical Solutions Ltd.
17.3.2.1 Company Overview
17.3.2.2 Product Portfolio
17.3.2.3 Financials
17.3.3 Boston Scientific Corporation
17.3.3.1 Company Overview
17.3.3.2 Product Portfolio
17.3.3.3 Financials
17.3.3.4 SWOT Analysis
17.3.4 Cardinal Health Inc.
17.3.4.1 Company Overview
17.3.4.2 Product Portfolio
17.3.4.3 Financials
17.3.4.4 SWOT Analysis
17.3.5 Contego Medical LLC
17.3.5.1 Company Overview
17.3.5.2 Product Portfolio
17.3.6 Innovative Cardiovascular Solutions LLC
17.3.6.1 Company Overview
17.3.6.2 Product Portfolio
17.3.7 Edwards Lifesciences Corporation
17.3.7.1 Company Overview
17.3.7.2 Product Portfolio
17.3.7.3 Financials
17.3.7.4 SWOT Analysis
17.3.8 Medtronic Inc.
17.3.8.1 Company Overview
17.3.8.2 Product Portfolio
17.3.8.3 Financials
17.3.8.4 SWOT Analysis
17.3.9 Silk Road Medical Inc.
17.3.9.1 Company Overview
17.3.9.2 Product Portfolio
17.3.9.3 Financials